Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)

Rationale Aspirin-exacerbated respiratory disease (AERD) is characterized by acute respiratory reactions after ingestion of aspirin. The inclusion criteria were as follows: (1) adults older than 18 years; (2) asthma gathered by a physician; (3) nasal polyps confirmed by computed tomography scan of t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB97-AB97
Main Authors: Andrade, Mayra Coutinho, Pacheco, Rosilane dos Reis, Almeida, Mila, Takejima, Priscila, Kalil Filho, Jorge Elias, Giavina-Bianchi, Pedro, Agondi, Rosana C.
Format: Article
Language:English
Subjects:
Aspirin
Inflammation
Nonsteroidal anti-inflammatory drugs
Respiratory diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page AB97
container_issue 2
container_start_page AB97
container_title Journal of allergy and clinical immunology
container_volume 141
creator Andrade, Mayra Coutinho
Pacheco, Rosilane dos Reis
Almeida, Mila
Takejima, Priscila
Kalil Filho, Jorge Elias
Giavina-Bianchi, Pedro
Agondi, Rosana C.
description Rationale Aspirin-exacerbated respiratory disease (AERD) is characterized by acute respiratory reactions after ingestion of aspirin. The inclusion criteria were as follows: (1) adults older than 18 years; (2) asthma gathered by a physician; (3) nasal polyps confirmed by computed tomography scan of the paranasal sinuses and/or nasal endoscopy; (4) aspirin/nonsteroidal anti-inflammatory drug (NSAID) sensitivity.
doi_str_mv 10.1016/j.jaci.2017.12.310
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2007520390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674917322108</els_id><sourcerecordid>2007520390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1680-b484416eacafe0a5cf756eb76336309ea983dd5cd2deaaed91529d8a909f74283</originalsourceid><addsrcrecordid>eNp9kMtqGzEUhkVIoE6aF-hK0E26mOmR5irIxjhJG0hJMCldimPpDNFga1xJDvEmz1657rqrc-H_z-Vj7JOAUoBov47liMaVEkRXCllWAk7YTIDqiraXzSmbAShRtF2tPrDzGEfIddWrGXu_C_R7R97s-ePA5z65wvlhjZsNpins-ZLWmMjyxS6hp2kX-Q_0bqCYMLnJ83vPn3JGPkX-y6UXPo9bF5wv6A0NhdVf85IOzePAGxcJI_Gr-e3y5stHdjbgOtLlv3jBft7dPi--Fw-P3-4X84fCiLaHYlX3dS1aQoMDATZm6JqWVl1bVW0FilD1lbWNsdISIlklGqlsjwrU0NWyry7Y5-PcbZjyuzHpcdoFn1dqCdA1EioFWSWPKhOmGAMNehvcBsNeC9AHznrUB876wFkLqTPnbLo-mijf_-oo6GgyD0PWBTJJ28n9z_4HFpCH2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007520390</pqid></control><display><type>article</type><title>Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)</title><source>Elsevier</source><creator>Andrade, Mayra Coutinho ; Pacheco, Rosilane dos Reis ; Almeida, Mila ; Takejima, Priscila ; Kalil Filho, Jorge Elias ; Giavina-Bianchi, Pedro ; Agondi, Rosana C.</creator><creatorcontrib>Andrade, Mayra Coutinho ; Pacheco, Rosilane dos Reis ; Almeida, Mila ; Takejima, Priscila ; Kalil Filho, Jorge Elias ; Giavina-Bianchi, Pedro ; Agondi, Rosana C.</creatorcontrib><description>Rationale Aspirin-exacerbated respiratory disease (AERD) is characterized by acute respiratory reactions after ingestion of aspirin. The inclusion criteria were as follows: (1) adults older than 18 years; (2) asthma gathered by a physician; (3) nasal polyps confirmed by computed tomography scan of the paranasal sinuses and/or nasal endoscopy; (4) aspirin/nonsteroidal anti-inflammatory drug (NSAID) sensitivity.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2017.12.310</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Aspirin ; Inflammation ; Nonsteroidal anti-inflammatory drugs ; Respiratory diseases</subject><ispartof>Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB97-AB97</ispartof><rights>2017</rights><rights>Copyright Elsevier Science Ltd. Feb 1, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Andrade, Mayra Coutinho</creatorcontrib><creatorcontrib>Pacheco, Rosilane dos Reis</creatorcontrib><creatorcontrib>Almeida, Mila</creatorcontrib><creatorcontrib>Takejima, Priscila</creatorcontrib><creatorcontrib>Kalil Filho, Jorge Elias</creatorcontrib><creatorcontrib>Giavina-Bianchi, Pedro</creatorcontrib><creatorcontrib>Agondi, Rosana C.</creatorcontrib><title>Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)</title><title>Journal of allergy and clinical immunology</title><description>Rationale Aspirin-exacerbated respiratory disease (AERD) is characterized by acute respiratory reactions after ingestion of aspirin. The inclusion criteria were as follows: (1) adults older than 18 years; (2) asthma gathered by a physician; (3) nasal polyps confirmed by computed tomography scan of the paranasal sinuses and/or nasal endoscopy; (4) aspirin/nonsteroidal anti-inflammatory drug (NSAID) sensitivity.</description><subject>Aspirin</subject><subject>Inflammation</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Respiratory diseases</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtqGzEUhkVIoE6aF-hK0E26mOmR5irIxjhJG0hJMCldimPpDNFga1xJDvEmz1657rqrc-H_z-Vj7JOAUoBov47liMaVEkRXCllWAk7YTIDqiraXzSmbAShRtF2tPrDzGEfIddWrGXu_C_R7R97s-ePA5z65wvlhjZsNpins-ZLWmMjyxS6hp2kX-Q_0bqCYMLnJ83vPn3JGPkX-y6UXPo9bF5wv6A0NhdVf85IOzePAGxcJI_Gr-e3y5stHdjbgOtLlv3jBft7dPi--Fw-P3-4X84fCiLaHYlX3dS1aQoMDATZm6JqWVl1bVW0FilD1lbWNsdISIlklGqlsjwrU0NWyry7Y5-PcbZjyuzHpcdoFn1dqCdA1EioFWSWPKhOmGAMNehvcBsNeC9AHznrUB876wFkLqTPnbLo-mijf_-oo6GgyD0PWBTJJ28n9z_4HFpCH2w</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Andrade, Mayra Coutinho</creator><creator>Pacheco, Rosilane dos Reis</creator><creator>Almeida, Mila</creator><creator>Takejima, Priscila</creator><creator>Kalil Filho, Jorge Elias</creator><creator>Giavina-Bianchi, Pedro</creator><creator>Agondi, Rosana C.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>201802</creationdate><title>Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)</title><author>Andrade, Mayra Coutinho ; Pacheco, Rosilane dos Reis ; Almeida, Mila ; Takejima, Priscila ; Kalil Filho, Jorge Elias ; Giavina-Bianchi, Pedro ; Agondi, Rosana C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1680-b484416eacafe0a5cf756eb76336309ea983dd5cd2deaaed91529d8a909f74283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aspirin</topic><topic>Inflammation</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Respiratory diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrade, Mayra Coutinho</creatorcontrib><creatorcontrib>Pacheco, Rosilane dos Reis</creatorcontrib><creatorcontrib>Almeida, Mila</creatorcontrib><creatorcontrib>Takejima, Priscila</creatorcontrib><creatorcontrib>Kalil Filho, Jorge Elias</creatorcontrib><creatorcontrib>Giavina-Bianchi, Pedro</creatorcontrib><creatorcontrib>Agondi, Rosana C.</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrade, Mayra Coutinho</au><au>Pacheco, Rosilane dos Reis</au><au>Almeida, Mila</au><au>Takejima, Priscila</au><au>Kalil Filho, Jorge Elias</au><au>Giavina-Bianchi, Pedro</au><au>Agondi, Rosana C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2018-02</date><risdate>2018</risdate><volume>141</volume><issue>2</issue><spage>AB97</spage><epage>AB97</epage><pages>AB97-AB97</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Rationale Aspirin-exacerbated respiratory disease (AERD) is characterized by acute respiratory reactions after ingestion of aspirin. The inclusion criteria were as follows: (1) adults older than 18 years; (2) asthma gathered by a physician; (3) nasal polyps confirmed by computed tomography scan of the paranasal sinuses and/or nasal endoscopy; (4) aspirin/nonsteroidal anti-inflammatory drug (NSAID) sensitivity.</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2017.12.310</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB97-AB97
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_2007520390
source Elsevier
subjects Aspirin
Inflammation
Nonsteroidal anti-inflammatory drugs
Respiratory diseases
title Frequency Of Anti-inflammatory Related Cutaneous Manifestation In Patients With Aspirin-exacerbated Respiratory Disease (AERD)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A06%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequency%20Of%20Anti-inflammatory%20Related%20Cutaneous%20Manifestation%20In%20Patients%20With%20Aspirin-exacerbated%20Respiratory%20Disease%20(AERD)&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Andrade,%20Mayra%20Coutinho&rft.date=2018-02&rft.volume=141&rft.issue=2&rft.spage=AB97&rft.epage=AB97&rft.pages=AB97-AB97&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2017.12.310&rft_dat=%3Cproquest_cross%3E2007520390%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1680-b484416eacafe0a5cf756eb76336309ea983dd5cd2deaaed91529d8a909f74283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2007520390&rft_id=info:pmid/&rfr_iscdi=true